WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

FDA findings lead to medical journal paper retraction | The Jerusalem Post

An Amgen spokesperson said it "takes scientific integrity seriously and respects the role of journals in upholding the peer review process."

Raccontata daendpoints.newsjpost.commedpagetoday.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
jpost.comStai leggendo1 g fa

FDA findings lead to medical journal paper retraction | The Jerusalem Post

An Amgen spokesperson said it "takes scientific integrity seriously and respects the role of journals in upholding the peer review process."

originale
endpoints.news1 g fa

NEJM retracts pivotal data for Amgen's Tavneos

NEJM retracts pivotal data behind Amgen's Tavneos after FDA probe finds results for 9 patients re-evaluated post-unblinding; EU also moves to revoke.

Leggi questa versione → originale
medpagetoday.com1 g fa

NEJM Retracts Pivotal Trial of FDA-Approved Drug

Move follows actions 'inconsistent with proper research conduct,' journal says

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 29 giugno 2026·endpoints.news

    NEJM retracts pivotal data for Amgen's Tavneos

    NEJM retracts pivotal data behind Amgen's Tavneos after FDA probe finds results for 9 patients re-evaluated post-unblinding; EU also moves to revoke.

  2. martedì 30 giugno 2026·jpost.com

    FDA findings lead to medical journal paper retraction | The Jerusalem Post

    An Amgen spokesperson said it "takes scientific integrity seriously and respects the role of journals in upholding the peer review process."

  3. martedì 30 giugno 2026·medpagetoday.com

    NEJM Retracts Pivotal Trial of FDA-Approved Drug

    Move follows actions 'inconsistent with proper research conduct,' journal says